Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab035Source: DataRank Database

Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial is a research paper published in The Journal of Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.19)OA: bronzeTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Abigail R. Gress,Samuel D Libby,Christine E. Ronayne,William E. Matchett ORCID,Brooke Noren

Live enrichment

PubMed:33476387 PMC:PMC7928927 OpenAlex:https://openalex.org/W3123383499

National Institutes of Health

Grant: T32AI055433

National Institutes of Health

Grant: T32HL774126

National Institutes of Health

Grant: 1R01AI153602

NIAID NIH HHS

Grant: R01 AI153602

UMN Department of Medicine

FWCI

0.19

Citation Percentile

0.5%

Citation Trend

2023

2024

bronzeLicense: https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model

journalhttps://academic.oup.com/jid/article-pdf/223/8/1339/37313752/jiab035.pdf

publisherhttps://academic.oup.com/jid/article-pdf/223/8/1339/37313752/jiab035.pdf

publisherhttp://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiab035/36585602/jiab035.pdf

publisherhttp://academic.oup.com/jid/article-pdf/223/8/1339/37313752/jiab035.pdf

journalhttps://doi.org/10.1093/infdis/jiab035

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

MeSH Terms

COVID-19SARS-CoV-2COVID-19 Drug TreatmentAdenosine MonophosphateAdultAlanineAntibodies, ViralAntiviral AgentsFemaleHumansImmunityMaleCytokines

Keywords

MedicineCoronavirusImmune systemImmunologyCytokineAntibodyDiseasePlaceboInternal medicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)PathologySerologyNeutralizationTrajectoryRemdesivirCovid-19Actt-1

Sustainable Development Goals

SDG 0: Good health and well-being